Further, peripheral blood vs. tumor samples should be comparably processed to explore the inflamed-tissue or peripheral LUAD specific distribution of IL-37 as a demand of local or systemic immunoregulation, as previously described in other immune-mediated inflammatory disorders [105,106]. This evidence concerns the gene IL37 and neoplasm.